DK1474143T3 - Fremgangsmåder og sammensætninger til bahandling af mandlig erektil dysfunktion - Google Patents

Fremgangsmåder og sammensætninger til bahandling af mandlig erektil dysfunktion

Info

Publication number
DK1474143T3
DK1474143T3 DK03707504T DK03707504T DK1474143T3 DK 1474143 T3 DK1474143 T3 DK 1474143T3 DK 03707504 T DK03707504 T DK 03707504T DK 03707504 T DK03707504 T DK 03707504T DK 1474143 T3 DK1474143 T3 DK 1474143T3
Authority
DK
Denmark
Prior art keywords
compositions
methods
erectile dysfunction
treating male
male erectile
Prior art date
Application number
DK03707504T
Other languages
Danish (da)
English (en)
Inventor
Ramsey Sallis
Quoc Huan Ha
Original Assignee
Modular Properties Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Modular Properties Ltd filed Critical Modular Properties Ltd
Application granted granted Critical
Publication of DK1474143T3 publication Critical patent/DK1474143T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/417—Imidazole-alkylamines, e.g. histamine, phentolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
DK03707504T 2002-01-25 2003-01-24 Fremgangsmåder og sammensætninger til bahandling af mandlig erektil dysfunktion DK1474143T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35163402P 2002-01-25 2002-01-25
PCT/US2003/002082 WO2003063776A2 (en) 2002-01-25 2003-01-24 Methods and compositions for treating male erectile dysfunction

Publications (1)

Publication Number Publication Date
DK1474143T3 true DK1474143T3 (da) 2009-01-26

Family

ID=27663012

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03707504T DK1474143T3 (da) 2002-01-25 2003-01-24 Fremgangsmåder og sammensætninger til bahandling af mandlig erektil dysfunktion

Country Status (9)

Country Link
US (1) US7405222B2 (de)
EP (1) EP1474143B1 (de)
AT (1) ATE406900T1 (de)
AU (1) AU2003209350A1 (de)
CY (1) CY1108631T1 (de)
DE (1) DE60323332D1 (de)
DK (1) DK1474143T3 (de)
PT (1) PT1474143E (de)
WO (1) WO2003063776A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090257956A1 (en) * 2002-01-25 2009-10-15 Ramsey Sallis Treatment Method for Treatment of Erectile Dysfunction and Premature Ejaculation
US20090035221A1 (en) * 2002-01-25 2009-02-05 Ramsey Sallis Methods and Compositions for Treatment of Erectile Dysfunction
US8287474B1 (en) 2002-08-22 2012-10-16 Koenig J Frank Method and apparatus for noninvasively increasing whole body blood flow and noninvasive physical exercise of limbs from the outside and from within the limb to treat diseases throughout the body
KR101086147B1 (ko) 2003-03-21 2011-11-25 넥스메드 홀딩스 인코포레이티드 조루증 치료용 조성물 및 치료 방법
DE102006022554B4 (de) * 2006-05-15 2014-12-04 Roche Diagnostics Gmbh Verfahren und Vorrichtung zum Stimulieren eines Gewebes für die subkutane Verabreichung von Wirkstoffen
US7718595B2 (en) * 2008-06-17 2010-05-18 Colgate Palmolive Company Light duty liquid cleaning compositions and methods of manufacture and use thereof comprising organic acids
US8147848B2 (en) 2009-08-26 2012-04-03 Allergan, Inc. Method for treating premature ejaculation with a botulinum neurotoxin
US9192613B1 (en) 2014-10-14 2015-11-24 Sapere Ip, Llc Treatment method for primary premature ejaculation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4127118B1 (en) 1977-03-16 1995-12-19 Alvaro Latorre Method of effecting and enhancing an erection
US5256652A (en) * 1987-11-12 1993-10-26 Pharmedic Co. Topical compositions and methods for treatment of male impotence
FR2649613B1 (fr) * 1989-07-11 1991-09-27 Virag Ronald Medicament vaso-actif
GB9423910D0 (en) 1994-11-26 1995-01-11 Pfizer Ltd Therapeutic agents
US6323211B1 (en) 1996-02-02 2001-11-27 Nitromed, Inc. Compositions and methods for treating sexual dysfunctions
US6127363A (en) * 1997-10-28 2000-10-03 Vivus, Inc. Local administration of Type IV phosphodiesterase inhibitors for the treatment of erectile dysfunction
US6200591B1 (en) 1998-06-25 2001-03-13 Anwar A. Hussain Method of administration of sildenafil to produce instantaneous response for the treatment of erectile dysfunction
GB9823102D0 (en) 1998-10-23 1998-12-16 Pfizer Ltd Pharmaceutically active compounds
US6303135B1 (en) 1999-07-08 2001-10-16 Neal R. Cutler Use of quinolines and quinolones to treat male erectile dysfunction
US6323241B1 (en) 2000-01-10 2001-11-27 Nexmed (Holdings) Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction

Also Published As

Publication number Publication date
EP1474143B1 (de) 2008-09-03
US20030144318A1 (en) 2003-07-31
WO2003063776A3 (en) 2003-10-23
DE60323332D1 (de) 2008-10-16
ATE406900T1 (de) 2008-09-15
WO2003063776A2 (en) 2003-08-07
EP1474143A4 (de) 2005-05-11
EP1474143A2 (de) 2004-11-10
US7405222B2 (en) 2008-07-29
PT1474143E (pt) 2009-01-02
AU2003209350A1 (en) 2003-09-02
CY1108631T1 (el) 2014-04-09

Similar Documents

Publication Publication Date Title
CY1108631T1 (el) Μεθοδοι και συνθεσεις για τη θεραπεια στυτικης δυσλειτουργιας των ανδρων
DK2198876T3 (da) Fremgangsmåde til nedsættelse af sandsynligheden for implantationssvigt i et individ
DE60335743D1 (de) Verbindungen und verfahren zur erhöhung der neurogenese
CY1118520T1 (el) Θεραπεια ινωσης χρησιμοποιωντας εκλεκτικους συνδετες fxr
CY1107478T1 (el) Η χρηση της τραμαδολης για καθυστερηση της εκσπepματισης
BRPI0309665B8 (pt) método para analisar uma preparação de alfagalactosidase a
DK1651161T3 (da) Farmaceutiske præparater og fremgangsmåder til at fremme sårheling
ECSP045520A (es) Metodos de tratamiento con inhibidores de la ptec y agentes antihipertensivos
CY1109783T1 (el) Μεθοδοι και συνθεσεις για την αντιμετωπιση της φλεγμονωδους νοσου του πεπτικου
ATE548025T1 (de) Inhalierbare zubereitungen zur behandlung pulmonarer hypertensie und methoden zu ihrer verwendung
DK1112075T3 (da) Præparater til behandling af mandlig erektil dysfunktion
NO20052401L (no) Mantelapparat for medisinsk anordning og fremgangsmate for fremstilling og anvendelse av den samme.
EA201000245A1 (ru) Человеческие нейтрализующие антитела к фактору роста нервов (ngf) в качестве селективных ингибиторов метаболического пути ngf
NO20050717L (no) Metode og sammensetninger for modulering av T hjelpe (TH) celleutvikling og funksjon
HUP0401590A2 (hu) Eljárások allogén sziget átültetés védelmére oldható CTLA4 mutáns molekulák alkalmazásával
MA28909B1 (fr) Quinazolines utiles en tant que modulateurs de canaux ioniques
DK1680097T3 (da) Præparater til topisk påföring og fremgangsmåder til afgivelse af et aktivt middel til et substrat
WO2007136910A3 (en) Eimmunotherapy for immune suppressed patients
NO20053626L (no) Blanding omfattende en kombinasjon av en aromataseinhibitor, et progestin og et ostrogen for anvendelse av behandling av endomeriose
DK1471936T3 (da) HIV-Vaccine og fremgangsmåde til anvendelse
EA200601871A1 (ru) Способы лечения аутоиммунных и воспалительных заболеваний
EA200501166A1 (ru) Составы и способы лечения тромбоцитемии
DE60232244D1 (de) Nachweis und behandlung von prostatakrebs
WO2002053143A3 (en) Treatment of erectile dysfunction with rho-kinase inhibitors
EP1930009A3 (de) Verfahren und Zusammensetzungen zur Behandlung der männlichen erektilen Dysfunktion